- Tytuł:
- Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)
- Autorzy:
- Źródło:
- In Transplantation and Cellular Therapy March 2024
Czasopismo naukowe